Commentary: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia.
作者信息
Jacobs Jeremy W, Booth Garrett S, Allen Elizabeth S, Adkins Brian D
机构信息
Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, United States.
Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN, United States.
出版信息
Front Immunol. 2023 Jan 27;14:1133382. doi: 10.3389/fimmu.2023.1133382. eCollection 2023.
Abstract
摘要
相似文献
1
Commentary: Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia.
Front Immunol. 2023 Jan 27;14:1133382. doi: 10.3389/fimmu.2023.1133382. eCollection 2023.
2
Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Transfus Clin Biol. 2019 May;26(2):112-115. doi: 10.1016/j.tracli.2019.02.003. Epub 2019 Feb 22.
3
Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia.
Front Immunol. 2022 Nov 29;13:1055473. doi: 10.3389/fimmu.2022.1055473. eCollection 2022.
4
Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Arch Intern Med. 1988 Nov;148(11):2485-9.
5
Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.
Blood. 2012 Jul 19;120(3):528-37. doi: 10.1182/blood-2011-11-327361. Epub 2012 May 4.
6
Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
Transfusion. 2009 Aug;49(8):1649-54. doi: 10.1111/j.1537-2995.2009.02185.x.
7
Red blood cell alloimmunization in sickle cell disease patients in Uganda.
Transfusion. 2010 Jan;50(1):20-5. doi: 10.1111/j.1537-2995.2009.02435.x. Epub 2009 Oct 10.
8
Alloimmunization to transfused HOD red blood cells is not increased in mice with sickle cell disease.
Transfusion. 2012 Feb;52(2):231-40. doi: 10.1111/j.1537-2995.2011.03255.x. Epub 2011 Jul 25.
9
Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
Indian J Med Res. 2019 Jan;149(1):34-40. doi: 10.4103/ijmr.IJMR_940_17.
10
[Transfusion and alloimmunization in sickle cell anemia patients].
Transfus Clin Biol. 1994;1(1):27-34. doi: 10.1016/s1246-7820(05)80054-0.
引用本文的文献
1
Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions.
Am J Hematol. 2024 Dec;99(12):2351-2366. doi: 10.1002/ajh.27487. Epub 2024 Sep 26.
本文引用的文献
1
Case report: Daratumumab treatment in pre-transplant alloimmunization and severe hemolytic anemia.
Front Immunol. 2022 Nov 29;13:1055473. doi: 10.3389/fimmu.2022.1055473. eCollection 2022.
2
RBC alloimmunization and daratumumab: Are efforts to eliminate interferences and prevent new antibodies necessary?
Transfusion. 2021 Dec;61(12):3283-3285. doi: 10.1111/trf.16736. Epub 2021 Nov 12.
3
Antibody incidence and red blood cell transfusions in patients on daratumumab.
Transfusion. 2021 Dec;61(12):3468-3472. doi: 10.1111/trf.16687. Epub 2021 Oct 7.
4
Optimizing transfusion management of multiple myeloma patients receiving daratumumab-based regimens.
Transfusion. 2021 Jul;61(7):2054-2063. doi: 10.1111/trf.16425. Epub 2021 May 7.
5
The evanescence and persistence of RBC alloantibodies in blood donors.
Transfusion. 2020 Apr;60(4):831-839. doi: 10.1111/trf.15718. Epub 2020 Feb 15.
6
Hemolytic transfusion reactions in sickle cell disease: underappreciated and potentially fatal.
Haematologica. 2020 Mar;105(3):539-544. doi: 10.3324/haematol.2019.224709. Epub 2020 Feb 6.
7
Risk of RBC alloimmunization in multiple myeloma patients treated by Daratumumab.
Vox Sang. 2020 Feb;115(2):207-212. doi: 10.1111/vox.12864. Epub 2019 Nov 14.
8
Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
Transfus Clin Biol. 2019 May;26(2):112-115. doi: 10.1016/j.tracli.2019.02.003. Epub 2019 Feb 22.
9
Transfusion-related red blood cell alloantibodies: induction and consequences.
Blood. 2019 Apr 25;133(17):1821-1830. doi: 10.1182/blood-2018-08-833962. Epub 2019 Feb 26.
10
The impact of Daratumumab on transfusion service costs.
Transfusion. 2019 Apr;59(4):1252-1258. doi: 10.1111/trf.15134. Epub 2019 Jan 8.
Zotero 插件